FDA Approves First mRNA Flu Vaccine But Limits Use to Older Adults

(MedPage Today) -- The FDA approved the trivalent flu vaccine mRNA-1010 (mFLUSIVA) for use in all adults age 50 years or older, Moderna announced on Wednesday. It is the first approved flu vaccine to use the mRNA technology that sped COVID-19 vaccine...